| Data Entry |
Update CPDMS edits for COVID-19 date fields with the following rules:
- Covid19DiagDate must be be blank (-1) or year must be 2019-current year
- Covid19DxStgTxDelayDate must be be blank (-1) or year must be 2019-current year
- Covid19AbTestDate must be be blank (-1) or year must be 2019-current year
- Covid19ViralTestDate must be be blank (-1) or year must be 2019-current year
- Covid19DiagDate cannot be blank (-1) when Covid19Diagnosis is 1
- Covid19DxStgTxDelayDate cannot be blank (-1) when Covid19DxStgTxDelay is 1
- Covid19ViralTestDate cannot be blank (-1) when Covid19ViralTest is 1
- Covid19AbTestDate cannot be blank (-1) when Covid19AbTest is 1
|
| Data Entry |
Added CPDMS edit checks for the Neoadjuvant Therapy Treatment Effect field:
- Ensure the code is valid for the case schema
- Compare to the Response to Neoadjuvant Therapy SSDI for breast cases to ensure proper coding
|
| Data Entry |
Updated drop down lists for EOD/SSDI fields and the Neoadjuvant Therapy-Treatment Effect field to show the description text for that choice, and truncate long descriptions. (Full descriptions for the options can be reached through the help pages.)
Additionally, the Neoadjuvant Therapy-Treatment Effect field will now only show options specific to the case schema. |
| Data Entry |
Updated Regional Nodes Positive/AJCC TNM N stage CPDMS edit check to allow staging combinations where all N stage values are blank. |
| Reports |
Updated SEER Follow-Up Report to reflect the metrics available in SEER*DMS:
- Split out report for invasive cancers by age brackets <20, 20-64, 65+ and added an In Situ report
- Updated calculation of follow-up dates and percentages
- Allow diagnosis year range instead of single diagnosis year
|
| Data Entry |
Added a CPDMS edit to check that Gleason Score Clinical matches Grade Clinical |